HOME >> MEDICINE >> NEWS
Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone

Combining pre-operative chemotherapy and surgery increases the average chance of survival at five years by approximately 6% compared with surgery alone.

This conclusion was drawn by a team of Cochrane Researchers from the MRC Clinical Trials Unit in London after they identified 12 eligible randomised controlled trials. Data from seven of these trials were available from trial reports and were combined in a meta-analysis. The seven trials involved a total of 988 patients.

This is currently the best estimate of the effectiveness of this therapy, but is based on a relatively small number of trials and patients, says lead researcher Sarah Burdett.

There was, however, insufficient data to break the patients down into sub-groups and see whether the effectiveness varies for different types of patients or stages of the disease.

This research is important because around the world more than a million new cases of lung cancer are diagnosed each year, around 80% of which are non-small cell lung cancer. In addition, many patients are only diagnosed after the disease has progressed, so survival rates across all stages of disease tend to be fairly low at around 14%, with only a quarter of patients being suitable for surgery.

The Cochrane Systematic Review found that using chemotherapy before surgery can reduce the size of tumours making the surgery simpler, and increasing the number of patients who may be candidates for surgery. The worry is, however, that having a course of chemotherapy delays the operation, and could therefore leave patients at risk of allowing the tumour to spread.

The data suggest that the benefits of the chemotherapy outweigh the risks associated with the delay, says Burdett

A project to collect complete data on all patients included in all trials is ongoing and will be able to fully assess the value of this treatment.


'"/>

Contact: Jennifer Beal
jbeal@wiley.co.uk
44-012-437-70633
John Wiley & Sons, Inc.
17-Jul-2007


Page: 1

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. Stomach cancer rate set to fall further 25 percent over next decade
4. MRI finds breast cancer before it becomes dangerous
5. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
6. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
7. Pathway links inflammation, angiogenesis and breast cancer
8. Using MRI for diagnosis could help prevent breast cancer progression
9. Electric fields have potential as a cancer treatment
10. Shining light on pancreatic cancer
11. Method shows promise for early detection of pancreatic cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2019)... ... September 12, 2019 , ... ... and national scale in two recent and well-renowned listing publications, the Inc. 5000 ... businesses for the 2019 year. , Dr. Jeffrey Donaldson, CEO and owner ...
(Date:9/11/2019)... ... September 11, 2019 , ... Global Education Group (Global), ... (CME) provider, is the official accreditor for PAINWeek, the largest US pain conference ... topics, as it has done for the past ten years. In addition, the ...
(Date:9/11/2019)... ... , ... Autopsies don’t lie. They report the causes of death as ... harms the heart. It increases risks of heart attack and death. Autopsies ... damage occurs. , An August 1, 2019 article in U.S. News ...
(Date:9/11/2019)... OAK, Mich. (PRWEB) , ... September 10, 2019 , ... ... The new office is location at 32686 Woodward Ave, Suite 103, Royal Oak, ... mile. , “Our Royal Oak location offers comprehensive women’s health services in a contemporary, ...
(Date:9/11/2019)... , ... September 10, 2019 , ... ... critical support to the most vulnerable communities impacted by Hurricane Dorian. , ... South Carolina, the Episcopal Diocese of Georgia, and the Episcopal Farmworker Ministry, Episcopal ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... September 14, 2019 , ... On September 11, 2019, after ... jury in Middlesex County found Johnson & Johnson liable for causing the Plaintiffs’ ... caused by asbestos-containing J&J talc products. , A unanimous jury found ...
(Date:9/12/2019)... LAKE CITY (PRWEB) , ... September 12, 2019 ... ... USA are collaborating to help make the services of CPESN’s clinically integrated network ... providers and payers. CPESN USA’s participating pharmacies provide high quality clinical service ...
(Date:9/11/2019)... , ... September 11, 2019 , ... ... analysis, with many companies developing technologies to evaluate medical images. In fact, image ... understands the approaches the FDA is taking to AI-based image analysis, one will ...
Breaking Medicine Technology:
Cached News: